Search Results - "Ribeiro de Sousa, Graziella"
-
1
The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology
Published in Journal of molecular medicine (Berlin, Germany) (01-04-2020)“…Glioblastoma is the most common aggressive primary brain tumor. Standard care includes maximal safe surgical resection, radiation, and chemotherapy with…”
Get full text
Journal Article -
2
Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia
Published in Hematology, Transfusion and Cell Therapy (01-01-2021)“…Aberrant expression of long non-coding RNAs (lncRNAs) has been detected in several types of cancer, including acute lymphoblastic leukemia (ALL), but lncRNA…”
Get full text
Journal Article -
3
A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods
Published in Journal of molecular medicine (Berlin, Germany) (01-08-2021)“…Although ependymoma (EPN) molecular subgroups have been well established by integrated high-throughput platforms, low- and middle-income countries still need…”
Get full text
Journal Article -
4
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study
Published in Neuro-oncology (Charlottesville, Va.) (03-10-2023)“…Abstract Background Ependymoma (EPN) posterior fossa group A (PFA) has the highest rate of recurrence and the worst prognosis of all EPN molecular groups. At…”
Get full text
Journal Article -
5
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma
Published in Neuro-oncology (Charlottesville, Va.) (05-01-2023)“…Supratentorial RELA fusion (ST-RELA) ependymomas (EPNs) are resistant tumors without an approved chemotherapeutic treatment. Unfortunately, the molecular…”
Get full text
Journal Article -
6
Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression
Published in Cancer gene therapy (01-06-2020)“…RELA -fused supratentorial (ST) ependymoma (EPN) is an aggressive subgroup with poor prognosis. Considering the putative role of Notch signaling in the…”
Get full text
Journal Article -
7
Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values
Published in Journal of molecular neuroscience (01-03-2022)“…The Group 3 Medulloblastoma (Grp3-MB) is an aggressive molecular subtype with a high incidence of metastasis and deaths. In this study, were used an RNA…”
Get full text
Journal Article -
8
Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas
Published in Acta neuropathologica communications (28-09-2023)“…Plexiform neurofibroma (PN) is a leading cause of morbidity in children with the genetic condition Neurofibromatosis Type 1 (NF1), often disfiguring or…”
Get full text
Journal Article -
9
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells
Published in Human cell : official journal of Human Cell Research Society (01-11-2023)“…Groups (Grp) 3 and 4 are aggressive molecular subgroups of medulloblastoma (MB), with high rates of leptomeningeal dissemination. To date, there is still a…”
Get full text
Journal Article -
10
The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma
Published in Neurological sciences (01-03-2020)“…Background Ependymoma (EPN) is the third most common childhood cancer of the central nervous system. RELA fusion-positive EPN accounts for approximately 70% of…”
Get full text
Journal Article -
11
YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells
Published in Cancers (13-12-2021)“…Advances in genomics have led to the identification of twelve relevant molecular subtypes within medulloblastoma (MB). The alpha subtype of Sonic…”
Get full text
Journal Article -
12
Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors
Published in Molecular biology reports (01-08-2020)“…TP53 p.R337H germline mutation is highly prevalent in the Southern region of Brazil. We sought to investigate TP53 p.R337H mutation in pediatric tumor samples…”
Get full text
Journal Article -
13
Should we keep rocking? Portraits from targeting Rho kinases in cancer
Published in Pharmacological research (01-10-2020)“…[Display omitted] •The Rho-associated coiled-coil kinases (ROCK1 and ROCK2) gained popularity and progressively been researched as anti-cancer targets.•Their…”
Get full text
Journal Article -
14
SIGMAR1 Knockdown Enhances Oral Cancer Cell Chemosensitivity to Cisplatin via Decreased PD-L1 Expression
Published in International journal of molecular sciences (05-11-2024)“…Emerging evidence suggests that aberrant expression levels of Sigma1 (SIGMAR1, also known as sigma-1 receptor) have been implicated in the progression of…”
Get full text
Journal Article -
15
Full-house nephropathy associated with high expression of SPATA5L1 due to a genetic pathogenic variant
Published in Rheumatology (Oxford, England) (11-04-2022)Get full text
Journal Article -
16
Abstract A22: YAP1 knockout in vitro models of medulloblastoma showed improved response to sonidegib
Published in Cancer research (Chicago, Ill.) (15-07-2020)“…Background: Medulloblastoma (MB) is the most common malignant brain tumor in childhood. Despite improvement in current treatment, children still suffer from…”
Get full text
Journal Article -
17
Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies
Published in Child's nervous system (01-02-2021)“…Purpose Somatic mutations on H3 histone are currently considered a genetic hallmark for midline pediatric high-grade gliomas (HGGs). Yet, different tumor…”
Get full text
Journal Article -
18
Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study
Published in Child's nervous system (01-07-2021)“…Purpose Inhalation of perillyl alcohol (POH) recently emerged as an investigational promising antiglioma strategy. However, little attention has been paid to…”
Get full text
Journal Article -
19
A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review
Published in Child's nervous system (01-04-2019)“…Background Ependymoma (EPN) is the third most common central nervous system tumor in childhood. Recent advances in the molecular classification of EPN revealed…”
Get full text
Journal Article -
20
Abstract 1034: SIGMAR1 as a novel potential prognostic biomarker that regulates PD-L1 expression in oral cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Background: The SIGMAR1 receptor is a regulator of immunity and inflammation. Together, these key processes can support or restrain cancer progression and…”
Get full text
Journal Article